Corrigendum: Arachidonate 15-lipoxygenase-mediated production of Resolvin D5n-3 DPA abrogates pancreatic stellate cell-induced cancer cell invasion

Gabriel A Aguirre; Michelle R Goulart; Barts Pancreas Tissue Bank; Jesmond Dalli; Hemant M Kocher

doi:10.3389/fimmu.2024.1353835

Corrigendum: Arachidonate 15-lipoxygenase-mediated production of Resolvin D5_{n-3 DPA} abrogates pancreatic stellate cell-induced cancer cell invasion

Front Immunol. 2024 Jan 24:15:1353835. doi: 10.3389/fimmu.2024.1353835. eCollection 2024.

Authors

Gabriel A Aguirre¹, Michelle R Goulart¹, Barts Pancreas Tissue Bank¹, Jesmond Dalli^#², Hemant M Kocher^#¹

Affiliations

¹ Centre for Tumour Biology, Barts Cancer Institute, London, United Kingdom.
² William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, John Vane Science Centre, Queen Mary University of London, London, United Kingdom.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1248547.].

Keywords: ALOX15; CAF subtypes; all-trans retinoic acid; cancer-associated fibroblast; lipid mediator; pancreatic ductal adenocarcinoma; specialized pro-resolving mediator.

Publication types

Published Erratum